Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Garry

Showing results (351-360 of 380) with videos related to

Pageof 38
Sort By:
The Lancet. Infectious Diseases|July 4, 2024
Lassa fever research priorities: towards effective medical countermeasures by the end of the decadeKristine A Moore, Julia T Ostrowsky, Angela J Mehr, et al.
BMJ Open|December 23, 2025
Understanding the pathogenesis of uveitis in Ebola virus disease survivors: an observational cohort and cross-sectional study protocol for clinical, molecular virologic and immunologic characterisationCaleb D Hartley, Susanne Linderman, Tolulope Fashina, et al.
Ebiomedicine|April 7, 2018
Ebola Virus Persistence in Ocular Tissues and Fluids (EVICT) Study: Reverse Transcription-Polymerase Chain Reaction and Cataract Surgery Outcomes of Ebola Survivors in Sierra LeoneJessica G Shantha, John G Mattia, Augustine Goba, et al.
Nature Communications|August 19, 2020
Deployable CRISPR-Cas13a diagnostic tools to detect and report Ebola and Lassa virus cases in real-timeKayla G Barnes, Anna E Lachenauer, Adam Nitido, et al.
Plos One|January 14, 2025
Correction: A prospective, multi-site, cohort study to estimate incidence of infection and disease due to Lassa fever virus in West African countries (the Enable Lassa research programme)-Study protocolSuzanne Penfold, Ayola Akim Adegnika, Danny Asogun, et al.
Plos One|March 30, 2023
A prospective, multi-site, cohort study to estimate incidence of infection and disease due to Lassa fever virus in West African countries (the Enable Lassa research programme)-Study protocolSuzanne Penfold, Ayola Akim Adegnika, Danny Asogun, et al.
NPJ Vaccines|May 3, 2026
Searching for immune correlates in Lassa vaccine development - workshop reportTrevor Brasel, Polina Brangel, Ifedayo Adetifa, et al.
Scientific Reports|April 14, 2018
Field validation of recombinant antigen immunoassays for diagnosis of Lassa feverMatthew L Boisen, Jessica N Hartnett, Jeffrey G Shaffer, et al.
Scientific Reports|May 28, 2020
Field evaluation of a Pan-Lassa rapid diagnostic test during the 2018 Nigerian Lassa fever outbreakMatthew L Boisen, Eghosa Uyigue, John Aiyepada, et al.
Viruses|November 26, 2014
Nomenclature- and database-compatible names for the two Ebola virus variants that emerged in Guinea and the Democratic Republic of the Congo in 2014Jens H Kuhn, Kristian G Andersen, Sylvain Baize, et al.
Pageof 38

Showing results (351-360 of 380) with videos related to

Sort By:
Pageof 38
The Lancet. Infectious Diseases|July 4, 2024
Lassa fever research priorities: towards effective medical countermeasures by the end of the decadeKristine A Moore, Julia T Ostrowsky, Angela J Mehr, et al.
BMJ Open|December 23, 2025
Understanding the pathogenesis of uveitis in Ebola virus disease survivors: an observational cohort and cross-sectional study protocol for clinical, molecular virologic and immunologic characterisationCaleb D Hartley, Susanne Linderman, Tolulope Fashina, et al.
Ebiomedicine|April 7, 2018
Ebola Virus Persistence in Ocular Tissues and Fluids (EVICT) Study: Reverse Transcription-Polymerase Chain Reaction and Cataract Surgery Outcomes of Ebola Survivors in Sierra LeoneJessica G Shantha, John G Mattia, Augustine Goba, et al.
Nature Communications|August 19, 2020
Deployable CRISPR-Cas13a diagnostic tools to detect and report Ebola and Lassa virus cases in real-timeKayla G Barnes, Anna E Lachenauer, Adam Nitido, et al.
Plos One|January 14, 2025
Correction: A prospective, multi-site, cohort study to estimate incidence of infection and disease due to Lassa fever virus in West African countries (the Enable Lassa research programme)-Study protocolSuzanne Penfold, Ayola Akim Adegnika, Danny Asogun, et al.
Plos One|March 30, 2023
A prospective, multi-site, cohort study to estimate incidence of infection and disease due to Lassa fever virus in West African countries (the Enable Lassa research programme)-Study protocolSuzanne Penfold, Ayola Akim Adegnika, Danny Asogun, et al.
NPJ Vaccines|May 3, 2026
Searching for immune correlates in Lassa vaccine development - workshop reportTrevor Brasel, Polina Brangel, Ifedayo Adetifa, et al.
Scientific Reports|April 14, 2018
Field validation of recombinant antigen immunoassays for diagnosis of Lassa feverMatthew L Boisen, Jessica N Hartnett, Jeffrey G Shaffer, et al.
Scientific Reports|May 28, 2020
Field evaluation of a Pan-Lassa rapid diagnostic test during the 2018 Nigerian Lassa fever outbreakMatthew L Boisen, Eghosa Uyigue, John Aiyepada, et al.
Viruses|November 26, 2014
Nomenclature- and database-compatible names for the two Ebola virus variants that emerged in Guinea and the Democratic Republic of the Congo in 2014Jens H Kuhn, Kristian G Andersen, Sylvain Baize, et al.
Pageof 38